Abstract:Ovarian cancer is among the leading causes of cancer deaths in women. The low survival rate is in part due to inadequate means of detection, which emphasizes the need to develop effective screening techniques. Peptide J18 was previously discovered using phage display technology and was found to specifically target and image human ovarian tumors in a SKOV‐3 xenografted mouse model. Here, affinity maturation of J18 was carried out to improve its binding affinity by conducting an alanine scan of the peptide. A cell‐based modified ELISA using SKOV‐3 cells was carried out and dose‐response curves were modelled using non‐linear regression. The results showed that substitution of serine‐5 (S5) and aspartic acid‐6 (D6) with alanine decreased the EC50 value of the original peptide J18 from 45.02 µM (39.15‐52.94 95% confidence interval; CI) to 19.54 (9.70‐38‐51 95% CI) and 6.92 (5.2‐9.80 95% CI), respectively. Next, a double alanine substitution of S5 and D6 (J18‐S5A‐D6A) was investigated to further increase the binding affinity. The EC50 value was determined to be 4.22 (2.16‐16.14 95% CI), thus improving the binding affinity approximately 10‐fold. To ensure that J18‐S5A‐D6A maintained specificity for ovarian cancer cells, the peptide was evaluated against ovarian cancer SKOV‐3, pancreatic cancer Mia‐Paca‐2, prostate cancer LNCaP, and embryonic kidney HEK 293 cells using a modified ELISA and fluorescent microscopy. Both assays showed significantly increased binding of J18‐S5A‐D6A to SKOV‐3 cells compared to the other cell lines. Based on these results, peptide J18‐S5A‐D6A may be used as an improved imaging agent of ovarian cancer.

Screening and Identification of a Specific Binding Peptide to Ovarian Cancer Cells from a Phage-Displayed Peptide Library

In Vitro Screening of Ovarian Tumor Specific Peptides from a Phage Display Peptide Library

The selection and primary characterization of a 12mer peptide targeting ovarian cancer cells

Selection and identification of a specific peptide binding to ovarian cancer cells from a phage-displayed peptide library

In Vivo Screening with Ph . D .7 TM and Identification of Ovarian Cancer A 2780 Cell Targeted

A Novel Peptide Specifically Targeting Ovarian Cancer Identified by in Vivo Phage Display.

Screening and identification of a specific peptide binding to cervical cancer cells from a phage-displayed peptide library

Screening of a specific peptide binding to esophageal squamous carcinoma cells from phage displayed peptide library.

Screening and Characterization of Multipeptide Binding Specifically to Gastric Cancer Cells by Phage Peptide Library

[Screening Tumor Antigens of Ovarian Carcinoma by Western Blot, Immunoprecipitation, and Mass Spectrometry].

Screening and identification of a specific peptide binding to breast cancer cells from a phage-displayed peptide library

Construction and identification of human ovarian carcinoma cDNA phage expression library

Screening and Identification of a Specific Peptide Binding to Hepatocellular Carcinoma Cells from a Phage Display Peptide Library

Cell Adhesion and Invasion Inhibitory Effect of an Ovarian Cancer Targeting Peptide Selected Via Phage Display in Vivo

Screening and Identification of a Renal Carcinoma Specific Peptide from a Phage Display Peptide Library

A Multiplex Methylation-Specific Pcr Assay For Detection Of Early-Stage Ovarian Cancer Using Cell-Free Serum Dna

Screening and Identification of Phage-Displayed Polypeptides Specifically Binding to Human Gastric Cancer with High Metastatic Potential to Peritoneum

Identification of a Peptide for Folate Receptor Alpha by Phage Display and Its Tumor Targeting Activity in Ovary Cancer Xenograft

Affinity Maturation of an Ovarian Cancer‐Targeting Peptide

Screening of Molecular Markers for Early Diagnosis of Colorectal Cancer by Phage-Peptide Library

Selection and Characterization of a Peptide Specifically Targeting to Gastric Cancer Cell Line SGC-7901 Using Phage Display